Description:

RTOG-0525 F1: Follow-Up Form NCT00304031 Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FD9AAA90-325E-6D58-E034-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FD9AAA90-325E-6D58-E034-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 8/26/12
  2. 1/9/15
  3. 6/16/15
Uploaded on:

June 16, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

RTOG-0525 F1: Follow-Up Form NCT00304031

Radiation Therapy Oncology Group Phase III Lung Pre-Op Chemotherapy vs. Pre-Op Concurrent Chemoradiation for NSCLC

Clinical trial administrative data
AMENDED DATA
Assessment
Patient Vital Status
Patient Death Primary Reason
Karnofsky Performance Status
Neurological Function Status
Disease Progression
Has the patient been diagnosed with first regional recurrence or progression
Method of Evaluation
Non-Protocol Therapy
Is the patient receiving any non-protocol cancer therapy not previously reported?
Non protocol surgery
Was there gross evidence of tumor?
Was RT necrosis present
Non-protocol Therapy To Brain
Non-Protocol Radiation Therapy?
Non-Protocol Radiosurgery?
Non-Protocol brachytherapy
Non-Protocol Chemotherapy
Corticosteroids
Anticonvulsants
Chemotherapy
Other
New or continuing adverse events
Was a follow up scan performed
Footer